Monday saw good news from the world of novel coronavirus vaccine development with US company Moderna announcing positive interim results from ongoing human trials for its Covid-19 vaccine candidate. And back home, Bharat Biotech said it is starting late-stage trials of the indigenously developed vaccine candidate Covaxin.
